Segui
Rawle Francis
Titolo
Citata da
Citata da
Anno
Development of highly potent and selective diaminothiazole inhibitors of cyclin-dependent kinases
E Schonbrunn, S Betzi, R Alam, MP Martin, A Becker, H Han, R Francis, ...
Journal of medicinal chemistry 56 (10), 3768-3782, 2013
872013
Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening
TL Chiu, J Solberg, S Patil, TW Geders, X Zhang, S Rangarajan, ...
Journal of chemical information and modeling 49 (12), 2726-2734, 2009
322009
Small molecule/nucleic acid affinity chromatography: application for the identification of telomerase inhibitors which target its key RNA/DNA heteroduplex
C West, R Francis, SH Friedman
Bioorganic & medicinal chemistry letters 11 (20), 2727-2730, 2001
302001
Targeting telomerase via its key RNA/DNA heteroduplex
R Francis, C West, SH Friedman
Bioorganic Chemistry 29 (2), 107-117, 2001
292001
The anti-parasitic agent suramin and several of its analogues are inhibitors of the DNA binding protein Mcm10
CN Paulson, K John, RM Baxley, F Kurniawan, K Orellana, R Francis, ...
Open biology 9 (8), 190117, 2019
152019
Discovery and characterization of multiple classes of human CatSper blockers
EJ Carlson, R Francis, Y Liu, P Li, M Lyon, CM Santi, DJ Hook, ...
ChemMedChem 17 (15), e202000499, 2022
142022
The fungal sexual pheromone sirenin activates the human CatSper channel complex
SS Syeda, EJ Carlson, MR Miller, R Francis, DE Clapham, PV Lishko, ...
ACS chemical biology 11 (2), 452-459, 2016
142016
A rapid direct telomerase assay method using 96-well streptavidin plates
R Francis, SH Friedman
BioTechniques 32 (5), 1154-1160, 2002
112002
An interference-free fluorescent assay of telomerase for the high-throughput analysis of inhibitors
R Francis, SH Friedman
Analytical biochemistry 323 (1), 65-73, 2003
102003
Number of lethal equivalents in human populations: how good are the previous estimates?
JK Lee, M Lascoux, EV Nordheim
Heredity 77 (2), 209-216, 1996
91996
Screening through lead optimization of high affinity, allosteric cyclin-dependent kinase 2 (CDK2) inhibitors as male contraceptives that reduce sperm counts in mice
EB Faber, N Wang, K John, L Sun, HL Wong, D Burban, R Francis, D Tian, ...
Journal of medicinal chemistry 66 (3), 1928-1940, 2023
82023
The discovery of high affinity and metabolically stable allosteric cyclin-dependent kinase 2 (CDK2) inhibitors from screening through lead optimization
EB Faber, N Wang, K John, L Sun, D Burban, HL Wong, R Francis, D Tian, ...
2022
CatSper as a Target for Male Contraception
D Diering, E Carlson, M Miller, R Francis, J Hawkinson, P Lishko, G Georg
2016
Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitor scaffolds using in silico and in vitro high-throughput screening methodologies
TL Chiu, J Solberg, S Patil, TW Geders, X Zhang, S Rangarajan, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 240, 2010
2010
Advancing anthrax toxin countermeasures using topomeric searching and virtual screening methodologies
EA Amin, TL Chiu, DJ Hook, MA Walters, BC Finzel, J Solberg, S Patil, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 240, 2010
2010
Discovery by high throughput screening and kinase profiling of optimized CDK2 inhibitors as male contraceptive agents
R Francis, A Becker, H Han, KM Baehr, B Trinczek, R Chakrasali, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 238, 2009
2009
A high throughput screening FRET assay for identification of novel anthrax toxin lethal factor inhibitors
EA Amin, D Hook, S Patil, MA Walters, R Francis, TL Chiu, J Solberg, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 237, 2009
2009
Inhibition of human telomerase by targeting its transitory RNA/DNA heteroduplex
R Francis
University of Missouri-Kansas City, 2005
2005
RNA/DNA heteroduplex as a target for telomerase inhibition.
SH Friedman, R Francis
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 225, U195-U195, 2003
2003
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–19